Objective Ada has developed a unique visual reasoning tool for medical professionals that offers diagnosis decision support at the point of care. The award-winning user-interface of Ada is designed to activate the interplay between analytical and integrative thinking skills of the physician. After three years of fundamental research in new reasoning technologies, Ada is now able to capture knowledge from medical experts, transform it into a medical reasoning engine and deliver it directly to the point-of-care in a patient-specific manner. The goal of Ada/DX is to help the doctor: i) avoid misdiagnosis, ii) support diagnosis decision-making for even the most complex cases in a robust and efficient way, iii) simultaneously document the diagnostic process according to both clinical and legal requirements. Reducing the number of misdiagnoses and wrong treatments can help to reduce personal suffering of the patients and healthcare costs simultaniously. A study revealed that misdiagnoses and wrong treatments in the field of vertigo diseases cost about 1 Billion EUR per year in Germany. According to a recent study on the Healthcare decision support field (WinterGreen research – 2013), wrong test and test that are not usefull in a particular situation, account for 30% of the costs of the healthcare delivery in the US. Overall the project will end in a full working Software as a Service (Saas) product. The M10-accuracy of today 85% will be increased to > 95%, by simultaneously increasing the number of common diseases from today 800 to 3.500 plus 6.000 rare diseases. Three user targeted products will be set up, adressing three market segments: GP-Service, Expert-Service, Prevention-Service. Fields of science medical and health scienceshealth scienceshealth care sciencesmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) ICT-37-2014 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-2-2014 Funding Scheme SME-2 - SME instrument phase 2 Coordinator ADA HEALTH GMBH Net EU contribution € 2 408 313,25 Address Adalbertstrasse 20 10997 Berlin Germany See on map Region Berlin Berlin Berlin Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 1 032 136,75
